ResMed Inc. (R1MD34)
Market Closed
12 Jun, 19:55
B3 B3 Primary R$
247. 24
-0.76
-0.3064%
R$
150.86B Market Cap
27.49 P/E Ratio
2.1% Div Yield
10 Volume
6.52 Eps
R$ 248
Previous Close Want to track R1MD34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ResMed Inc. (R1MD34) Statistics
Valuation metrics
Market Cap 150.86B
Enterprise value 185.38B
Trailing P/E (ttm) 20.04
Forward P/E -
PEG ratio 2
Price/Sales (ttm) 27.28
Price/Book (mrq) 4.63
Enterprise Value/Revenue 6.67
Enterprise Value/EBITDA 17.43
Overview
Shares outstanding 145.04M
Float 144.17M
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1
Average volume (90 days) 3
Price summary
52-Week low 243.27
52-Week high 397
Beta 0.84
50-Day moving average 282.48
200-Day moving average 332.65
Financials
Fiscal year
Fiscal year ends 30 Jun 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.27%
Operating margin 0.35%
Operational effectiveness
Return on assets 0.15%
Return on equity 0.25%
Income Statement
Revenue (ttm) 27.78B
Revenue per share (ttm) 9.48
Quarterly revenue growth (yoy) 0.11%
Gross profit (ttm) 17.28B
EBITDA 2.2B
Net income to common (ttm) 7.62B
Diluted EPS (ttm) 12.99
Quarterly earnings growth (yoy) 0.09%
Balance Sheet
Total cash (mrq) 8.33B
Total cash per share (mrq) 11.45
Total debt (mrq) 4.23B
Total Debt/Equity (mrq) 12.99
Current ratio (mrq) 3.01%
Book value per share (mrq) 56.26
Cash Flow
Cash flow statement 9.48B
Levered free cash flow (LFCF) 7.26B
